Because weight loss improves insulin sensitivity, many PCOS symptoms improve as well: more regular periods, reduced androgen levels (less acne, hirsutism), improved fertility, and better metabolic markers
The popular weight-loss drug Wegovy, which has helped millions of Americans shed pounds, can be used to reduce the risk of stroke, heart attacks and other serious cardiovascular problems in patients who are overweight or who have obesity, federal regulators said in March.
doi: 10.1161/CIRCULATIONAHA.125.074545 Summary Keywords cardiovascular outcomes, SGLT2 inhibitors, GLP-1 agonists, combination therapy, heart failure, renal outcomes Citation Aristizbal-Colorado D, Corredor-Rengifo D, Sierra-Castillo S, Lpez-Corredor C, Vernaza-Trujillo D-A, Weir-Restrepo D, Izquierdo-Condoy JS, Ortiz-Prado E, Rico-Fontalvo J, Gmez-Mesa J-E, Abreu-Lomba A and Rivera-Martnez W-A (2025) A decade of progress in type 2 diabetes and cardiovascular disease: advances in SGLT2 inhibitors and GLP-1 receptor agonists a comprehensive review
Eligible patients can complete a secure telehealth consultation
Tirzepatide Often Has Higher Costs and Stricter Insurance Requirements Semaglutide pricing varies by brand and use: Versions of semaglutide for diabetes and weight management are priced differently, and many insurance plans cover part of the cost
